The U.S. Preventive Services Task Force (USPSTF) is recommending sweeping
changes in its breast
cancer screening guidelines.
The USPSTF, which is a group of independent health experts convened by the
Department of Health and Human Services, reviewed and commissioned research to
develop computer-simulated models comparing the expected outcomes under
different screening scenarios.
Here are the USPSTF's recommendations, based on all that work:
Routine screening of average-risk women should begin at age 50, instead of
Routine screening should end at age 74.
Women should get screening mammograms every two years instead of every
Breast self-exams have little value, based on findings from several large
But the new recommendations may leave some women confused, since the
American Cancer Society continues to recommend annual mammography screening for all healthy women beginning
at age 40. What's the bottom line on mammogram screening? WebMD asked breast
cancer experts about the new USPSTF screening guidelines.
If a woman younger than 50 or older than 74 wants to get a screening mammogram, can she?
The guidelines don't ban anyone from getting a screening mammogram. But it's
not yet known if the new guidelines will affect mammography coverage by
insurance companies and other providers.
Task force vice-chair Diana B. Petitti, MD, tells WebMD the new guidelines
don't apply to women with risk factors for breast cancer, such as BRCA
mutations or a close family history of the disease.
She adds that they also do not mean average-risk women who are younger than
50 or older than 74 should never be screened.
"This is not telling [average-risk] women in these age groups they can't get
screened," Petitti says. "A woman who still wants to be screened after having
the conversation with her clinician and considering the balance of benefits and
harms should absolutely be screened."
Will insurance pay for a mammogram if I'm younger than 50 or older than 74?
As for paying for those mammograms, the USPSTF recommendations are
influential in guiding policy, but the group doesn't make specific
recommendations about reimbursement.
It remains to be seen if the sweeping health care bill now being considered
by Congress will reflect the new recommendations.